Qi et al. tried to explore the possible mechanism of IL-22 in regulating hyperandrogenism-associated PCOS, and they found that additional IL-22 treatment in PCOS-induced mice improved insulin-resistance, estrous cycle and ovary morphology. The gene discussed is IL22; the disease is polycystic ovary syndrome.